DIM
CLDI icon

Delta Investment Management’s Calidi Biotherapeutics CLDI Stock Holding History

Delta Investment Management’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-109
Closed -$4.83K – 276
2025
Q2 		$4.83K Hold
109
– – ﹤0.01% 239
2025
Q1 		$11.9K Hold
109
– – ﹤0.01% 238
2024
Q4 		$24.2K Hold
109
– – ﹤0.01% 254
2024
Q3 		$24K Hold
109
– – ﹤0.01% 243
2024
Q2 		$42K Buy
109
+104
+2,080% +$53.1K 0.01% 213
2024
Q1 		$5.78K Hold
5
– – ﹤0.01% 216
2023
Q4 		$15.4K Hold
5
– – ﹤0.01% 200
2023
Q3 		$34K Buy
+5
New +$81K 0.01% 178

Other funds holding CLDI

HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $533M AUM 20.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
AMH
Apollo Management Holdings New York $8.94B AUM 120.19% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Delta Investment Management's CLDI Position: Q3 2025 in Review

Delta Investment Management sold out of Calidi Biotherapeutics (CLDI) in Q3 2025, closing a stake of 109 shares — an estimated $4.83K sold.

Delta Investment Management first reported a position in CLDI in Q3 2023 and held it in 8 quarters. The position peaked at $42K in Q2 2024. 21 funds tracked by Wall St. Rank hold CLDI as of Q3 2025.

  • Delta Investment Management reported no remaining Calidi Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Delta Investment Management sold 109 Calidi Biotherapeutics shares in Q3 2025, an estimated $4.83K.
  • Delta Investment Management first reported a position in Calidi Biotherapeutics in Q3 2023 and held it in 8 quarters.
  • Delta Investment Management's Calidi Biotherapeutics position peaked at $42K in Q2 2024.
  • 21 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2025.

Based on Delta Investment Management's 13F filing for Q3 2025, filed 20 Oct 2025.